Peter Greenleaf
2018 - Avalo Therapeutics
In 2018, Peter Greenleaf earned a total compensation of $5.1M as Former Chief Executive Officer at Avalo Therapeutics, a 17,372% increase compared to previous year.
Compensation breakdown
| Bonus | $360,000 |
|---|---|
| Option Awards | $2,568,787 |
| Salary | $456,000 |
| Stock Awards | $1,696,000 |
| Other | $10,000 |
| Total | $5,090,787 |
Greenleaf received $2.6M in option awards, accounting for 50% of the total pay in 2018.
Greenleaf also received $360K in bonus, $456K in salary, $1.7M in stock awards and $10K in other compensation.
Rankings
In 2018, Peter Greenleaf's compensation ranked 1,962nd out of 14,244 executives tracked by ExecPay. In other words, Greenleaf earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,962 out of 14,244 | 86th |
Division Manufacturing | 708 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 234 out of 2,128 | 89th |
Industry group Drugs | 186 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 144 out of 1,391 | 90th |
Source: SEC filing on June 19, 2019.
Greenleaf's colleagues
We found six more compensation records of executives who worked with Peter Greenleaf at Avalo Therapeutics in 2018.
2018
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2018
Joseph Miller
Avalo Therapeutics
Chief Financial Officer
2018
James Harrell
Avalo Therapeutics
Executive Vice President, Marketing and External Communications
2018
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
2018
Robert Moscato
Avalo Therapeutics
Chief Operating Officer
2018
Simon Pedder
Avalo Therapeutics
Chairman
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019